Filipe Pereira
- Division of Molecular Medicine and Gene Therapy
- Cell Reprogramming in Hematopoiesis and Immunity
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- WCMM-Wallenberg Centre for Molecular Medicine
- LUCC: Lund University Cancer Centre
1 – 84 of 84
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses
(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #15 : Colliding Cellular Reprogramming Paths— An Interview with Dr. Stefan Stricker
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
Reprogramming Stars #10 : Modeling Cancer with Cellular Reprogramming-An Interview with Dr. Dung-Fang Lee
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #11 : Teaming Up to Uncover the Epitranscriptomics of Reprogramming - An Interview with Dr. Miguel Fidalgo and Dr. Diana Guallar
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #12 : At the Heart of In Vivo Reprogramming- An Interview with Dr. Li Qian
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Assessing efficacy and immune-stimulatory effects of tumor-derived dendritic cell reprogramming using immuno-competent 3D tumor spheroid model
2023) American Association for Cancer Research Annual Meeting 2023 In Cancer Research 83(7 Supplement).(
- Contribution to journal › Published meeting abstract
-
Mark
GATA2 mitotic bookmarking is required for definitive haematopoiesis
(
- Contribution to journal › Article
-
Mark
Reprogramming Cancer Cells to Antigen-presenting Cells
(
- Contribution to journal › Article
-
Mark
High-Throughput Drug Screening Revealed That Ciclopirox Olamine Can Engender Gastric Cancer Stem-like Cells
(
- Contribution to journal › Article
-
Mark
Orchestrating an immune response to cancer with cellular reprogramming
2023) In Genes and Immunity(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #13 : Establishing Connections with Cellular Reprogramming–An Interview with Dr. Daniella Rylander Ottosson
(
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells
(
- Contribution to journal › Article
-
Mark
Reprogramming Stars #6 : A Venture Based in Cellular Reprogramming-An Interview with Dr. Cristiana Pires
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #5 : Regeneration, a Natural Reprogramming Process-An Interview with Dr. Nicholas Leigh
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Compositions, constructs and vectors for cell reprogramming (NK cell reprogramming).
2022) WO2022129542(
- Patent › Patent
-
Mark
Reprogramming Stars #9 : Spacing Out Cellular Reprogramming-An Interview with Dr. Valentina Fossati
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Eliciting Anti-Tumor Immunity by Reprogramming Cancer Cells to Type 1 Conventional Dendritic Cells
2022) European Association for Cancer Research 2022 - Congress(
- Contribution to conference › Poster
-
Mark
Harnessing Dendritic Cell Reprogramming to Elucidate Mechanisms of Tumor Immunity
2022) Lund Stem Cell Center Retreat(
- Contribution to conference › Poster
-
Mark
HMGA1 has predictive value in response to chemotherapy in gastric cancer
(
- Contribution to journal › Article
-
Mark
Reprogramming primary melanoma cells to dendritic cell fate enhances tumor immunogenicity
2022) SITC Society for Immunotherapy of Cancer 2022(
- Contribution to conference › Poster
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
-
Mark
Direct Reprogramming of Mouse and Human Fibroblasts into Conventional Dendritic Cells Type 1
(
- Contribution to journal › Published meeting abstract
-
Mark
Reprogramming Stars #7 : Dynamic Pluripotent Stem Cell States and Their Applications-An Interview with Dr. Jun Wu
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #8 : A Synthetic Biology Approach to Cellular Reprogramming-An Interview with Dr. Katie Galloway
(
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Ontogenic shifts in cellular fate are linked to proteotype changes in lineage-biased hematopoietic progenitor cells
(
- Contribution to journal › Article
-
Mark
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
Reprogramming Stars #1 : Genome Programming through the Cell Cycle - An Interview with Dr. Tomomi Tsubouchi
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming, the Journal
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #2 : Reprogramming towards Neural Lineages - An Interview with Dr. Henrik Ahlenius
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #4 : A Reprogramming Approach for Parkinson's Disease-An Interview with Dr. Malin Parmar
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #3 : Mechanisms of iPSC Reprogramming-An Interview with Dr. Keisuke Kaji
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Compositions for reprogramming into dendritic cells type 2 competent for antigen presentation, methods and uses thereof
2021) WO2021105234(
- Patent › Patent
-
Mark
Compositions for reprogramming cells into plasmacytoid dendritic cells or interferon producing cells, methods and uses thereof
2021) WO2021069672(
- Patent › Patent
-
Mark
Restoring the immunogenicity of cancer cells with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
-
Mark
GATA2 at the mitosis-to-G1 transition is critical for definitive hematopoiesis
2021) 2021 Virtual Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology: ISEH 50th Annual Meeting In Experimental Hematology 100(Suppl). p.35-35(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Mononuclear phagocyte regulation by the transcription factor Blimp-1 in health and disease
(
- Contribution to journal › Scientific review
-
Mark
A SOX2 reporter system identifies gastric cancer stem-like cells sensitive to monensin
(
- Contribution to journal › Article
-
Mark
Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors
(
- Contribution to journal › Article
- 2019
-
Mark
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic coculture
(
- Contribution to journal › Article
-
Mark
Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
2019) In Journal of visualized experiments : JoVE(
- Contribution to journal › Article
-
Mark
Understanding and Modulating Immunity With Cell Reprogramming
(
- Contribution to journal › Scientific review
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells
(
- Contribution to journal › Article
-
Mark
Cooperative Transcription Factor Induction Mediates Hemogenic Reprogramming
2018) In Cell Reports(
- Contribution to journal › Article
-
Mark
Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof.
2018) WO2018185709A1(
- Patent › Patent
-
Mark
Ihor R. Lemischka (1953-2017)
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Transient HES5 Activity Instructs Mesodermal Cells toward a Cardiac Fate
(
- Contribution to journal › Article
-
Mark
High-throughput identification of small molecules that affect human embryonic vascular development
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(15). p.3022-3031(
- Contribution to journal › Article
-
Mark
Method for Programming Differentiated Cells into Hematopoietic Stem Cells
2017) WO2013116307A1(
- Patent › Patent
-
Mark
Programming antigen-presenting dendritic cells from fibroblasts
(
- Contribution to journal › Published meeting abstract
-
Mark
Optimized induction of human hemogenesis in adult fibroblasts
(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
The stem cell niche finds its true north
(
- Contribution to journal › Scientific review
-
Mark
Reprogramming mouse embryonic fibroblasts with transcription factors to induce a hemogenic program
2016) In Journal of Visualized Experiments(
- Contribution to journal › Article
-
Mark
Making a Hematopoietic Stem Cell
(
- Contribution to journal › Scientific review
-
Mark
Hematopoietic Reprogramming In Vitro Informs In Vivo Identification of Hemogenic Precursors to Definitive Hematopoietic Stem Cells
(
- Contribution to journal › Article
-
Mark
Zero footprint induction of human hemogenesis to study pathologic developmental hematopoiesis in fanconi anemia
(
- Contribution to journal › Published meeting abstract
-
Mark
Mechanisms underlying human hemogenic reprogramming
(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Tbx3 Controls Dppa3 Levels and Exit from Pluripotency toward Mesoderm
(
- Contribution to journal › Article
- 2014
-
Mark
'From blood to blood' : De-differentiation of hematopoietic progenitors to stem cells
(
- Contribution to journal › Scientific review
-
Mark
"There will be blood" from fibroblasts
(
- Contribution to journal › Scientific review
-
Mark
Direct conversion from mouse fibroblasts informs the identification of hemogenic precursor cells in vivo
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Induction of a hemogenic program in mouse fibroblasts
(
- Contribution to journal › Article
- 2012
-
Mark
Reprogramming cell fates : Insights from combinatorial approaches
(
- Contribution to journal › Scientific review
-
Mark
Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling
(
- Contribution to journal › Article
-
Mark
Zfp281 mediates Nanog autorepression through recruitment of the NuRD complex and inhibits somatic cell reprogramming
2012) In Proceedings of the National Academy of Sciences of the United States of America 109(40). p.16202-16207(
- Contribution to journal › Article
- 2011
-
Mark
Using heterokaryons to understand pluripotency and reprogramming
2011) In Philosophical Transactions of the Royal Society B: Biological Sciences 366(1575). p.2260-2265(
- Contribution to journal › Scientific review
- 2010
-
Mark
Short RNAs Are Transcribed from Repressed Polycomb Target Genes and Interact with Polycomb Repressive Complex-2
(
- Contribution to journal › Article
-
Mark
CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
(
- Contribution to journal › Article
-
Mark
Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators
(
- Contribution to journal › Article
-
Mark
ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency
(
- Contribution to journal › Article
-
Mark
Differences in the epigenetic and reprogramming properties of pluripotent and extra-embryonic stem cells implicate chromatin remodelling as an important early event in the developing mouse embryo
(
- Contribution to journal › Article
- 2009
-
Mark
REST selectively represses a subset of RE1-containing neuronal genes in mouse embryonic stem cells
(
- Contribution to journal › Article
-
Mark
Senescence impairs successful reprogramming to pluripotent stem cells
(
- Contribution to journal › Article
-
Mark
Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression
(
- Contribution to journal › Article
-
Mark
Hepatocytes and IL-15 : A favorable microenvironment for T cell survival and CD8+ T cell differentiation
(
- Contribution to journal › Article
-
Mark
Heterokaryon-based reprogramming for pluripotency
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2008
-
Mark
Protein interactions between CD2 and Lck are required for the lipid raft distribution of CD2
(
- Contribution to journal › Article
-
Mark
Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2
(
- Contribution to journal › Article
- 2006
-
Mark
Acquisition and extinction of gene expression programs are separable events in heterokaryon reprogramming
(
- Contribution to journal › Article
- 2005
-
Mark
Altered expression of CD1d molecules and lipid accumulation in the human hepatoma cell line HepG2 after iron loading
(
- Contribution to journal › Article
- 2004
-
Mark
Red blood cells as modulators to T cell growth and survival
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Red blood cells upregulate cytoprotective proteins and the labile iron pool in dividing human T cells despite a reduction in oxidative stress
(
- Contribution to journal › Article
-
Mark
Red blood cells promote survival and cell cycle progression of human peripheral blood T cells independently of CD58/LFA-3 and heme compounds
(
- Contribution to journal › Article